Imexpharm Corporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was VND 314,245.19 million compared to VND 296,437.02 million a year ago. Net income was VND 52,601.31 million compared to VND 41,855.49 million a year ago. Basic earnings per share from continuing operations was VND 694 compared to VND 615 a year ago.